Wade: RLYP price target of $27 sounds reasonable .... I don't think your short term $40 price target is realistic. Merrill sales forecast for 2016 is very disappointing, so let's hope they're wrong. I'm trading and hedging around a core position for now.
I have no interest in owning KERX at $5, but good luck with it. I think they'll need another cash infusion in a year from now just to stay afloat unless their drug sales suddenly zoom which I doubt.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.